Table 3 the influence of apoA1 genotypes on Lp(a) based on gender and a) diabetic (non-diabetic (T2DM-) and diabetic (T2DM+)) and b) CVD (without CVD (CVD-) and with established (CVD+)).
From: ApolipoproteinA1-75 G/A (M1-) polymorphism and Lipoprotein(a); Anti- vs. Pro-Atherogenic properties
a) | ||||||
|---|---|---|---|---|---|---|
Female ApoA-1 genotypes Lp(a) g/l | Male ApoA-1 genotypes Lp(a) g/l | |||||
M1 ++ | M1 +-/-- | P value | M1 ++ | M1 +-/-- | P value | |
T2DM - | 0.260(0.027) | 0.312(0.023) | <0.05 | 0.174(0.02) | 0.328(0.03) | <0.05 |
T2DM + | 0.190(0.018) | 0.420(0.038) | <0.05 | 0.146(0.014) | 0.149(0.09) | NS |
b) | ||||||
Female ApoA-1 genotypes Lp(a) g/l | Male ApoA-1 genotypes Lp(a) g/l | |||||
M1 ++ | M1 +-/-- | P value | M1 ++ | M1 +-/-- | P value | |
CVD - | 0.198(0.02) | 0.374(0.03) | <0.05 | 0.153(0.0.2) | 0.246(0.04) | <0.05 |
CVD + | 0.273(0.02) | 0.320(0.01) | NS | 0.218(0.02) | 0.190(0.018) | NS |